deltatrials
Terminated PHASE4 INTERVENTIONAL 1-arm NCT03044314

Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension (OVATION)

Outpatient Vasodilator Assessment Using Iloprost in Pulmonary Hypertension (The OVATION Study)

Sponsor: Actelion

Conditions Pulmonary Hypertension
Interventions Iloprost and nitric oxide administration
Updated 14 times since 2017 Last updated: Mar 6, 2024 Started: Jul 21, 2017 Primary completion: Jun 20, 2019 Completion: May 19, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

slow enrollment

Other terminated trials from Actelion

See all terminations from Actelion

Other Pulmonary Hypertension trials with similar outcome

Browse all Pulmonary Hypertension trials

A PHASE4 clinical study on Pulmonary Hypertension, this trial is terminated or withdrawn. The trial is conducted by Actelion and has accumulated 14 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshot~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshot~Oct 2018 – ~Jan 2019 · 3 months · monthly snapshot~Jan 2019 – ~Mar 2020 · 14 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Feb 2022 · 5 months · monthly snapshot~Feb 2022 – ~Apr 2022 · 59 days · monthly snapshot~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshot~Sep 2022 – ~May 2024 · 20 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. May 2024 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Sep 2022 — May 2024 [monthly]

    Terminated PHASE4

  5. Apr 2022 — Sep 2022 [monthly]

    Terminated PHASE4

▶ Show 9 earlier versions

  1. Feb 2022 — Apr 2022 [monthly]

    Terminated PHASE4

    Status: Recruiting → Terminated

  2. Sep 2021 — Feb 2022 [monthly]

    Recruiting PHASE4

  3. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE4

  4. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  5. Jan 2019 — Mar 2020 [monthly]

    Recruiting PHASE4

  6. Oct 2018 — Jan 2019 [monthly]

    Recruiting PHASE4

  7. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE4

  8. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  9. Feb 2017 — Sep 2017 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Actelion
  • Duke University
Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations